| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |

* From the Department of Anesthesiology, and
The Institute Of Transfusion Medicine, University Hospital, Rheinisch-Westfälische Technische Hochschule Aachen, Aachen, Germany.
Address correspondence to: Dr. Lothar W. de Rossi, Department of Anesthesiology, University Hospital, Rheinisch-Westfälische Technische Hochschule, Pauwelsstr. 30, D-52074 Aachen, Germany. Phone: +49-241-8088179; Fax: +49-241-8888406; E-mail: L.derossi{at}gmx.de
| Abstract |
|---|
|
|
|---|
Methods: Heparinized whole blood from 22 healthy volunteers was incubated for 60 min in the presence of 65% xenon. Sixty-five percent nitrous oxide was used as a positive control to prove the reliability of our in vitro system. Phagocytosis of fluorescein isothiocyanate labelled, opsonized Escherichia coli (E. coli) by neutrophils and monocytes was measured using flow cytometry. After induction with either N-formyl-methionyl-leucyl-phenylalanine (FMLP), phorbol-12-myristate-13-acetate or opsonized E. coli, respiratory burst activity was assessed by measuring the oxidation of dihydrorhodamine 123 to rhodamine 123 with a flow cytometer.
Results: Exposure of human whole blood to xenon increased the percentage of neutrophils showing phagocytosis (94 ± 3% vs 92 ± 4%; P < 0.01), and the amount of ingested bacteria (P < 0.01). Respiratory burst activity in neutrophils and monocytes was not affected by xenon. Nitrous oxide significantly reduced the percentage of neutrophils showing respiratory burst after FMLP stimulation. Furthermore, E. coli-induced stimulation resulted in a decreased number of reacting neutrophils (84 ± 15% vs 95 ± 5%; P < 0.05) and monocytes (70 ± 22% vs 83 ± 11%; P < 0.05) as well as a reduced production of hydrogen peroxide in both cell lines compared to control.
Conclusion: In contrast to nitrous oxide, xenon preserves neutrophil and monocyte antibacterial capacity in vitro.
| Introduction |
|---|
|
|
|---|
| Methods |
|---|
|
|
|---|
Blood samples were incubated for 60 min with either 65% xenon or 65% nitrous oxide, 21% oxygen and 5% carbon dioxide at 37°C. Untreated blood samples used as controls were placed in an incubator (Heraeus BB 16, Germany). Xenon was delivered as a gas/oxygen/carbon dioxide mixture using a low-P-mass flow meter (Type F-201C-FA-22-V and E-7300-AAA, HI-TEC Bronkhorst, The Netherlands). Nitrous oxide was delivered using a standard anesthetic machine (Cato, Dräger, Germany).
Gas concentrations within the box were continuously monitored using a multigas-analyzer (Datex Compact, Helsinki, Finland). Xenon gas concentrations were monitored with an Ecotec 500 Euro mass spectrometer (Leybold, Germany).
Phagocytosis activity was measured according to the recommendations of the manufactures, with minor modifications (Phagotest, Orpegen, Germany). This test measures the percentage of leukocytes showing phagocytosis and the phagocytic activity at the single cell level.3 In brief, after incubation, 100 µL heparinized whole blood were placed on ice. After ten minutes, 20 µL opsonized and fluorescein isothiocyanate (FITC)-labelled Escherichia coli (E. coli; 2 x 109 mL-1) were added for ten minutes at 37°C. After incubation, samples were placed again on ice to stop further phagocytosis. Then, 100 µL quenching solution (4°C) was added and the samples were washed with phosphate buffered saline (PBS; 250 g, five minutes, 4°C). The cell pellet was lyzed and fixed (Lysing Solution®, Becton-Dickinson, USA). The samples were washed again two times with PBS, and DNA staining was performed with 200 µL propidium iodide (1 mM).
A flow cytometric assay (Phagoburst, Orpegen, Germany) was used to assess the respiratory burst activity.3 This assay allows quantification of the percentage of leukocytes showing respiratory burst activity as well as the amount of generated hydrogen oxygen. In brief, after incubation, 100 µL heparinized whole blood were placed on ice for ten minutes. Three different stimuli were used: N-formyl-methionyl-leucyl-phenylalanine (FMLP; 100 nM), phorbol-12-mystritate-13-acetate (PMA, 100 nM) and opsonized E. coli, (20 µL, 2 x 10-9mL-1). After ten minutes of stimulation (37°C), 20 µL dihydrorhodamine 123 (DHR, 1 mM) was added and the samples were incubated for ten minutes at 37°C. The stimulation was stopped by adding 2 mL Lysing Solution®. After centrifugation (250 g, five minutes, 4°C), cells were washed twice with PBS (250 g, five minutes, 4°C) and the remaining cell pellet resuspended with PBS. DNA staining was performed with 200 µL propidium iodide (1 mM) for ten minutes on ice.
Flow cytometric analyses were performed on a FACSCalibur flow cytometer and analyzed using CellQuest 3.1 software (Becton-Dickinson, USA). Data acquisition and analyses were performed as previously described.13
In the phagocytosis assay, the percentage of FITC-positive neutrophils and monocytes reflects the percentage of cells containing FITC-labelled E. coli, whereas the mean FITC fluorescence intensity (MFI) correlates with the number of ingested bacteria per cell. In the respiratory burst assay, the percentage of rhodamine 123 positive phagocytes reflects the percentage of cells showing respiratory burst activity. The rhodamine 123 MFI is proportional to the amount of hydrogen peroxide generated by the individual phagocyte.
Statistical analysis
All data are presented as mean values and standard deviation. Differences between drug-exposed and untreated control samples assessed in parallel were evaluated using paired t test. P < 0.05 was considered significant.
| Results |
|---|
|
|
|---|
|
|
|
|
| Discussion |
|---|
|
|
|---|
Intracellular elimination of invading bacteria by neutrophils and monocytes depends mainly on the generation of reactive oxygen species during the phagocytosis-associated respiratory burst.4 To allow comparison with previous studies,1,2 respiratory burst activity was induced with FMLP as a physiological agonist. PMA, a direct activator of protein kinase C (PKC), was used to identify possible effects on the intracellular signaling pathway. Since phagocytosis depends upon direct contact of neutrophils and monocytes with bacteria,5 that have been opsonized by immune globulines and/or the complement component C3b, we also used opsonized E. coli as physiological stimulus of phagocytosis-related generation of respiratory burst.
After exposure to xenon neither neutrophils nor monocytes showed changes in their respiratory burst activity. In contrast, nitrous oxide reduced the amount of hydrogen peroxide produced per neutrophil after stimulation with FMLP, which is inconsistent with previous results.2 However, we could not detect a reduction in the percentage of neutrophils showing respiratory burst activity after exposure to nitrous oxide. This discrepancy might be explained by methodological differences.
An interesting new finding of our study was the inhibition of the E. coli-induced respiratory burst activity of neutrophil and monocytes by nitrous oxide. The signaling pathways activated by binding of IgG-opsonized bacteria to FcRs on the surface of neutrophils and monocytes are incompletely established. Engagement of the IgG-ligand leads to FcRs-receptor aggregation and activation of cytosolic tyrosine kinases, most notably Syk.5,6 Events downstream of Syk activation are less well known, but evidence suggests that cytoskeletal alterations and phagocytosis as well as respiratory burst activity are mediated by the GTPases Cdc42 and Rac.5,7 In the present study nitrous oxide did not affect FcRs-mediated phagocytosis and PMA-induced respiratory burst. Therefore, we suggest that nitrous oxide might interfere with the intracellular signaling pathway downstream of the GTPases Cdc42 and Rac, and upstream of PKC.
Xenon caused a small increase in the percentage of neutrophils showing phagocytosis and in the amount of ingested bacteria per cell. Enflurane has been shown to decrease phagocytosis,8 whereas halothane,9 isoflurane, and nitrous oxide8 had no effect. Neutrophil and monocyte phagocytosis activity following exposure to nitrous oxide was also not affected in our study. However, we suggest that the small increase in the phagocytic activity of neutrophils is clinically not important.
In conclusion, the results of our study show that xenon preserves neutrophil and monocyte antibacterial capacity in vitro.
| Footnotes |
|---|
Presentation: Parts of this manuscript were presented at the symposium "Current developments in anaesthesia", February 17th, Barcelona, Spain, and at the 11th European Congress of Anesthesiology, Florence, Italy, 59 June 2001.
Revision received August 9, 2002. Accepted for publication April 29, 2002.
| References |
|---|
|
|
|---|
2 Fröhlich D, Rothe G, Wittmann S, et al. Nitrous oxide impairs the neutrophil oxidative response. Anesthesiology 1998; 88: 128190.[Medline]
3 Heine J, Jaeger K, Osthaus A, et al. Anaesthesia with propofol decreases FMLP-induced neutrophil respiratory burst but not phagocytosis compared with isoflurane. Br J Anaesth 2000; 85: 42430.
4 Burg ND, Pillinger MH. The neutrophil: function and regulation in innate and humoral immunity. Clin Immunol 2001; 99: 717.[Medline]
5 Greenberg S. Modular components of phagocytosis. J Leukoc Biol 1999; 66: 7127.[Abstract]
6 Salmon JE, Brogle NL, Edberg JC, Kimberly RP. Fc receptor III induces actin polymerization in human neutrophils and primes phagocytosis mediated by Fc receptor II. J Immunol 1991; 146: 9971004.[Abstract]
7 Caron E, Hall A. Identification of two distinct mechanisms of phagocytosis controlled by different Rho GTPases. Science 1998; 282: 171721.
8 Welch WD. Effect of enflurane, isoflurane, and nitrous oxide on the microbicidal activity of human polymorphonuclear leukocytes. Anesthesiology 1984; 61: 18892.[Medline]
9 Nunn JF, Sturrock JE, Jones AJ, et al. Halothane does not inhibit human neutrophil function in vitro. Br J Anaesth 1979; 51: 11018.
This article has been cited by other articles:
![]() |
T. Kawasaki, M. Ogata, C. Kawasaki, K. Okamoto, and T. Sata Effects of epidural anaesthesia on surgical stress-induced immunosuppression during upper abdominal surgery Br. J. Anaesth., February 1, 2007; 98(2): 196 - 203. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. W. de Rossi, M. Brueckmann, S. Rex, M. Barderschneider, W. Buhre, and R. Rossaint Xenon and Isoflurane Differentially Modulate Lipopolysaccharide-Induced Activation of the Nuclear Transcription Factor KB and Production of Tumor Necrosis Factor-{alpha} and Interleukin-6 in Monocytes Anesth. Analg., April 1, 2004; 98(4): 1007 - 1012. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |